id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-N-0161-0008,FDA,FDA-2005-N-0161,"Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Current Good Manufacturing Practices for Blood and Related Regulations for and Blood Components; and Requirements for Donor Testing, Donor Notification, and ‘‘Lookback’’",Notice,Notice of Approval,2015-06-01T04:00:00Z,2015,6,2015-06-01T04:00:00Z,,2025-07-02T17:22:29Z,2015-13064,0,0,0900006481b11cc9
FDA-2005-N-0161-0007,FDA,FDA-2005-N-0161,"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practices and Related Regulations for Blood and Blood
Components; and Requirements for Donor Testing, Donor Notification, and ‘‘Lookback’’",Notice,30 Day Proposed Information Collection,2015-03-03T05:00:00Z,2015,3,2015-03-03T05:00:00Z,2015-04-03T03:59:59Z,2025-07-02T17:20:41Z,2015-04381,0,0,0900006481a26cb7